(Q39051622)

English

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

scientific article published on 30 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors (English)

1 reference

Europe PubMed Central

8 September 2017

0 references

7

object named as

Baris Turkbey

1 reference

Europe PubMed Central

8 September 2017

9

object named as

Peter Choyke

1 reference

Europe PubMed Central

8 September 2017

Seth M Steinberg

8

object named as

Seth M Steinberg

1 reference

Europe PubMed Central

8 September 2017

Shivaani Kummar

11

object named as

Shivaani Kummar

1 reference

Europe PubMed Central

8 September 2017

James H Doroshow

10

object named as

James H Doroshow

1 reference

Europe PubMed Central

8 September 2017

1

object named as

Woondong Jeong

1 reference

Europe PubMed Central

8 September 2017

Annamaria Rapisarda

2

object named as

Annamaria Rapisarda

1 reference

Europe PubMed Central

8 September 2017

3

object named as

Sook Ryun Park

1 reference

Europe PubMed Central

8 September 2017

Robert J Kinders

4

object named as

Robert J Kinders

1 reference

Europe PubMed Central

8 September 2017

Giovanni Melillo

6

object named as

Giovanni Melillo

1 reference

Europe PubMed Central

8 September 2017

author name string

Alice Chen

5

1 reference

Europe PubMed Central

8 September 2017

publication date

30 November 2013

1 reference

Europe PubMed Central

8 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

8 September 2017

73

1 reference

Europe PubMed Central

8 September 2017

2

1 reference

Europe PubMed Central

8 September 2017

343-348

1 reference

Europe PubMed Central

8 September 2017

https://scigraph.springernature.com/pub.10.1007/s00280-013-2362-z

0 references

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

Recent agents targeting HIF-1α for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

Targeting hypoxia cell signaling for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

Antisense oligonucleotides: the state of the art.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

Oligodeoxynucleotides containing alpha-L-ribo configured LNA-type C-aryl nucleotides

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2362-Z

21 January 2018

Identifiers

10.1007/S00280-013-2362-Z

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39051622&oldid=1806042452"